SOPHiA GENETICS 2025 Innovation Summit

AI-powered innovations to transform patient care​

June 11-12 |Boston, MA

 

EVENT DETAILS

June 11 | 6:30 pm | Exclusive Networking Dinner


June 12 | Event  Day | Agenda

 
8:30  Breakfast & Networking
9:00 

OPENING KEYNOTE: Promises and Challenges of Big Data Analytics in Healthcare
Pedram Razavi, MD, Ph.D, Breast Medical Oncologist - Memorial Sloan Kettering Cancer Center
9:20 

KEYNOTE: Unlocking the Power of Data: AI-Driven Insights for Precision Medicine
Jurgi Camblong, Ph.D, CEO and Co-Founder - SOPHiA GENETICS
9:40 

SPOTLIGHT – SOPHiA GENETICS Innovation Roadmap: What's Next?
Verena Schramm, M.Sc., VP, Product Management, SOPHiA GENETICS

Pushing the Boundaries of Germline Analysis
10:00 

KEYNOTE: Exploring the Clinical Potential of Whole Genome Sequencing
Mayana Zatz, Ph.D., Director of the Human Genome Research Center and Nacional Program: aging and genetics: genomics and metagenomics - University of Sao Paulo
10:20 

Coffee Break & Networking

Overcoming Cancer Complexity:
Real-World Impact of Genomic Innovations in Oncology
10:40 

The Advantages of Adopting NGS for Measurable Residual Disease in Acute Myeloid Leukemia
Juan C Gomez-Gelvez, MD, Pathologist - Henry Ford
11:00 

Enhancing the Potential of Comprehensive Genomic Profiling
Artur E. Rangel Filho, MD, Ph.D, Medical Director - Memorial Healthcare System
11:20

Targeting Solid Tumors with Precision: Insights into CDx Development
Jonathan Beer, MBA, Sr. Director, Diagnostic Sciences, Solid Tumors - Bristol Myers Squibb
10:40 

Lunch & Networking
13:15

The Future of Cancer Diagnostics: Exploring Liquid Biopsy at the MUHC  and Jewish General Hospital of Montreal
Alan Spatz, MD, Chief of the Department of Clinical Laboratory Medicine - McGill University Health Center
13:35

Innovations in Liquid Biopsy: Insights and Challenges from Tennessee Oncology
Thomas Stricker, MD, Ph.D, Technical Director of the Center for Genomics and Molecular Studies Laboratory -Tennessee Oncology
13:55

Diagnostic Strategies to Drive Successful Late-Stage Development
Ryan Demers, M.Sc., Global Diagnostics Director, Lung & Liquid Biopsy Strategy - AstraZeneca

Bridging Innovation Across Technologies
14:15

Achieving Universal Compatibility Without Compromising Quality
Amanda Verpoorte, Ph.D., Global Head of Platform Product Management - SOPHiA GENETICS
14:30

PANEL DISCUSSION: Increasing Efficiencies of Genomic Workflows Through Partnerships
Thomas Myers MBA, VP, Global Solutions Consulting - Rhapsody
Mike Klein, MBA, CEO - Genomenon Inc
Moderator: Wiley Gellar, Sr. Product Manager, SOPHiA GENETICS​​​​​
15:00 

Coffee Break & Networking

Unlocking the Power of Multimodal data
15:30

Setting a New Standard to Unveil data-driven Novel Insights
Loic Ferrer, Ph.D, Senior Manager Multimodal R&D - SOPHiA GENETICS
15:45

Pharma’s Perspective: Driving Innovation with Multimodal AI Data Analytics
Emmanuelle Di Tommaso Ph.D, VP, Global Head Translational - Bayer
16:05

PANEL DISCUSSION: AI and the Next Era of Precision Medicine
Pedram Razavi, MD, Ph.D, Breast Medical Oncologist - Memorial Sloan Kettering Cancer Center
David Rhew, MD, Chief Medical Officer & VP Healthcare - Microsoft
Jason Fenwick, Global Genomics Business Development - NVIDIA
Jonathan Beer, MBA, Sr. Director, Diagnostic Sciences, Solid Tumors - Bristol Myers Squibb
Emmanuelle Di Tommaso, VP, Global Head Translational - Bayer
Moderator: Jess Lambe, VP, Business Development BioPharma, SOPHiA GENETICS
16:50 

Closing Remarks
Ross Muken, President - SOPHiA GENETICS


*As a member of MedTech Europe, we are committed to complying with the MedTech Europe Code of Ethical Business Practice. Any arrangements involving the payment or reimbursement of travel, accommodation, or meal expenses will be made in strict accordance with the requirements of the Code, as well as all applicable national laws and regulations.

Register here for the event